打破障碍，定义并治疗 NK/T 细胞淋巴瘤。
Breaking Down the Barriers to Define and Treat NK/T Cell Lymphoma.
机构信息
Division of Hematology, Department of Internal Medicine, Ohio State University, Columbus, OH 43210, USA.
Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA; Broad Institute of MIT and Harvard University, Cambridge, MA 02142, USA.
出版信息
Cancer Cell. 2020 Mar 16;37(3):263-265. doi: 10.1016/j.ccell.2020.02.009.
In this issue of Cancer Cell, Xiong and colleagues describe the genomic and transcriptional landscape of natural killer/T cell lymphoma (NKTCL), a rare form of non-Hodgkin's lymphoma associated with EBV infection. They divide NKTCL into molecularly defined subtypes that could inform therapeutic strategies for patients with this deadly disease.
在本期《癌细胞》杂志中，熊教授及其同事描述了自然杀伤/T 细胞淋巴瘤（NKTCL）的基因组和转录组图谱，NKTCL 是一种与 EBV 感染相关的罕见非霍奇金淋巴瘤。他们将 NKTCL 分为分子定义的亚型，这可能为这种致命疾病的患者提供治疗策略。
Zotero 插件